Physician profile
William Cain
NPI 1952429888
$4,122.02
in general payments reported to CMS, 2019-2025
10 companies · $144 in 2025
The $144 reported for 2025 was more than what a typical Oral and Maxillofacial Pathology provider received nationally (typical 2025 total: $90.97).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $640 · 2020: $765 · 2021: $1,206 · 2022: $1,128 · 2023: $186 · 2024: $53.54 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $249 · Entertainment: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $249.32 |
| Entertainment | $134.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Keystone Dental INC. | $2,967.11 | 2019-2023 | |
| Depuy Synthes Sales INC. | $474.46 | 2019-2022 | |
| Nobel Biocare USA | $172.03 | 2019-2023 | Nobelactive |
| Geistlich Pharma, North America, INC. | $129.18 | 2021-2025 | Biomaterials |
| Stryker Corporation | $126.74 | 2019 | |
| Biohorizons Implant Systems INC. | $83.09 | 2021 | |
| Zimvie INC. | $72.78 | 2023-2024 | |
| Kls-Martin L.P. | $40.39 | 2019 | |
| Straumann USA LLC | $38.84 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $17.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Cain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.